A New Scoring Algorithm to Assess the Prognosis of Primary and Metastatic Breast Cancer with HER2-low Expression

被引：0
|
作者：
Miao, Jiaxian [1 ]
Shang, Jiuyan [1 ]
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
187
引用
收藏
页码：S222 / S224
页数：3
相关论文
共 50 条
  • [1] HER2-Low expression in primary male breast cancer
    Rudlowski, Christian
    Erices-Leclercq, Melanie
    Nobbe, Katleen
    Baldus, Stephan
    Foerster, Robert
    Foerster, Frank
    Lubig, Sabine
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 29 - 29
  • [2] New treatment options for metastatic HER2-low breast cancer
    Denkert, Carsten
    Lebeau, Annette
    Schildhaus, Hans Ulrich
    Jackisch, Christian
    Rueschoff, Josef
    PATHOLOGIE, 2023, 44 (02): : S53 - S60
  • [3] HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis
    Lin, Mingxi
    Luo, Ting
    Jin, Yizi
    Zhong, Xiaorong
    Zheng, Dan
    Zeng, Cheng
    Guo, Qing
    Wu, Jiong
    Shao, Zhi-Ming
    Hu, Xichun
    Yang, Wentao
    Zhang, Jian
    CANCER, 2024, 130 (06) : 851 - 862
  • [4] Frequency and prognosis of HER2-low status in Mexican patients with metastatic breast cancer
    Martinez-Cannon, Bertha Alejandra
    Verduzco-Aguirre, Haydee Cristina
    CANCER RESEARCH, 2023, 83 (05)
  • [5] Evolution of HER2-low expression from primary to recurrent breast cancer
    Miglietta, Federica
    Griguolo, Gaia
    Bottosso, Michele
    Giarratano, Tommaso
    Lo Mele, Marcello
    Fassan, Matteo
    Cacciatore, Matilde
    Genovesi, Elisa
    De Bartolo, Debora
    Vernaci, Grazia
    Amato, Ottavia
    Conte, PierFranco
    Guarneri, Valentina
    Dieci, Maria Vittoria
    NPJ BREAST CANCER, 2021, 7 (01)
  • [6] Evolution of HER2-low expression from primary to recurrent breast cancer
    Federica Miglietta
    Gaia Griguolo
    Michele Bottosso
    Tommaso Giarratano
    Marcello Lo Mele
    Matteo Fassan
    Matilde Cacciatore
    Elisa Genovesi
    Debora De Bartolo
    Grazia Vernaci
    Ottavia Amato
    PierFranco Conte
    Valentina Guarneri
    Maria Vittoria Dieci
    npj Breast Cancer, 7
  • [7] HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
    Agostinetto, Elisa
    Rediti, Mattia
    Fimereli, Danai
    Debien, Veronique
    Piccart, Martine
    Aftimos, Philippe
    Sotiriou, Christos
    de Azambuja, Evandro
    CANCERS, 2021, 13 (11)
  • [8] HER2-low metastatic breast cancer (MBC): Management and prognosis of a new breast cancer entity in a real-world setting
    Frenel, J-S.
    Lusque, A.
    Mailliez, A.
    Bachelot, T.
    Uwer, L.
    Reynier, M. A. Mouret
    Levy, C.
    Jouannaud, C.
    Goncalves, A.
    Patsouris, A.
    Dieras, V. C.
    Leheurteur, M.
    Petit, T.
    Cottu, P. H.
    Ferrero, J-M.
    Villacroux, O.
    D'Hondt, V.
    Desmoulins, I.
    Delaloge, S.
    De Calbiac, O.
    ANNALS OF ONCOLOGY, 2021, 32 : S491 - S491
  • [9] Genomic Characterization of Primary and Metastatic HER2-low Breast Cancers
    Marra, Antonio
    Safonov, Anton
    Drago, Joshua
    Ferraro, Emanuela
    Selenica, Pier
    Gazzo, Andrea
    Curigliano, Giuseppe
    Modi, Shanu
    Razavi, Pedram
    Reis-Filho, Jorge
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2023, 83 (05)
  • [10] Evaluation of HER2 scoring algorithms for identification of HER2-low breast cancer
    Costache, S.
    Nagy, A.
    Billingham, K.
    Haynes, H.
    Chefani, A.
    Thomas, T.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2020, 477 : S222 - S223
12345